Clinical outcomes of targeting therapy with BRAF/MEK inhibitors in patients with BRAF V600-mutated brain tumors

dc.conference.dateSEP 16-21, 2021
dc.conference.titleCongress of the European-Society-for-Medical-Oncology (ESMO)
dc.contributor.authorMejias Trueba, M.
dc.contributor.authorFernandez Rubio, B.
dc.contributor.authorPerez Moreno, M. A.
dc.contributor.authorSancho Marquez, M. P.
dc.contributor.authorAbder Kader, L.
dc.contributor.authoraffiliation[Mejias Trueba, M.] Hosp Univ Virgen Rocio, Pharmacy, Seville, Spain
dc.contributor.authoraffiliation[Fernandez Rubio, B.] Hosp Univ Virgen Rocio, Pharmacy, Seville, Spain
dc.contributor.authoraffiliation[Perez Moreno, M. A.] Hosp Univ Virgen Rocio, Pharmacy, Seville, Spain
dc.contributor.authoraffiliation[Abder Kader, L.] Hosp Univ Virgen Rocio, Pharmacy, Seville, Spain
dc.contributor.authoraffiliation[Sancho Marquez, M. P.] Hosp Univ Virgen Rocio, Oncol, Seville, Spain
dc.date.accessioned2025-01-07T15:50:53Z
dc.date.available2025-01-07T15:50:53Z
dc.date.issued2021-09-21
dc.identifier.doi10.1016/j.annonc.2021.08.039
dc.identifier.essn1569-8041
dc.identifier.issn0923-7534
dc.identifier.unpaywallURLhttps://doi.org/10.1016/j.annonc.2021.08.039
dc.identifier.urihttps://hdl.handle.net/10668/27446
dc.identifier.wosID700527700354
dc.issue.number5
dc.journal.titleAnnals of oncology
dc.journal.titleabbreviationAnn. oncol.
dc.language.isoen
dc.organizationSAS - Hospital Universitario Virgen del Rocío
dc.organizationSAS - Hospital Universitario Virgen del Rocío
dc.page.numberS527-S527
dc.publisherElsevier
dc.rights.accessRightsopen access
dc.titleClinical outcomes of targeting therapy with BRAF/MEK inhibitors in patients with BRAF V600-mutated brain tumors
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number32
dc.wostypeMeeting Abstract

Files